a month ago
NBIX
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 11%
#559 out of 5014 analysts
Average Return
+10.11%
Win Rate
56%68 out of 122
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-19 - 2023-09-25 | Strong Buy |
Phathom Pharmaceuticals IncPHAT | +328.99% | $2.76 | $11.84 | 2025-05-02 - 2025-09-12 | Strong Buy |
Vigil Neuroscience IncVIGL | +175.68% | $2.92 | $8.05 | 2024-08-14 - 2025-08-05 | Strong Buy |
Zenas Biopharma IncZBIO | +146.41% | $8.21 | $20.23 | 2025-03-12 - 2025-09-12 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +138.96% | $25.10 | $59.98 | 2024-01-02 - 2024-11-29 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
a month ago
ARGX
2 months ago
ABVX
10 months ago
ARGX
a year ago
SYRE
2 years ago
CLDX
2 years ago
AXSM
2 years ago
LBPH
2 years ago
ARGX
2 years ago
ARGX
2 years ago
LRMR
2 years ago
RXDX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.82% | Downgrades | 4 days ago |
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $100.00 | +169.11% | Maintains | 5 days ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | +610.23% | Initiates Coverage On | a month ago |
Cabaletta Bio IncCABA | 6 | Strong Buy | $15.00 | +715.22% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 7 | Strong Buy | $815.00 | +45.54% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $175.00 | +23.35% | Maintains | a month ago |
Argenx SeARGX | 10 | Strong Buy | $1,070.00 | +41.46% | Maintains | a month ago |
Abivax SaABVX | 2 | Strong Buy | $101.00 | +20.22% | Maintains | 2 months ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | +561.58% | Reiterates | 3 months ago |
Alumis IncALMS | 2 | Strong Buy | $18.00 | +311.90% | Reinstates | 3 months ago |
Anaptysbio IncANAB | 9 | Strong Buy | $90.00 | +284.62% | Maintains | 4 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | +142.88% | Maintains | 4 months ago |
Phathom Pharmaceuticals IncPHAT | 3 | Strong Buy | $12.00 | +1.35% | Maintains | 4 months ago |
Zura Bio LtdZURA | 2 | Strong Buy | $15.00 | +650.00% | Reiterates | 6 months ago |
Inflarx NvIFRX | 3 | Strong Buy | $10.00 | +693.65% | Maintains | 6 months ago |
Adicet Bio IncACET | 1 | Strong Buy | $7.00 | +764.20% | Reiterates | 6 months ago |
Zenas Biopharma IncZBIO | 2 | Strong Buy | $45.00 | +122.44% | Reiterates | 6 months ago |
Immunovant IncIMVT | 4 | Strong Buy | $44.00 | +172.28% | Maintains | 7 months ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | +289.07% | Upgrades | 8 months ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $65.00 | +315.34% | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 2 | Strong Buy | $16.00 | N/A | Maintains | a year ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $170.00 | N/A | Maintains | a year ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | a year ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Axsome Therapeutics IncAXSM | 7 | Strong Buy | $125.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Roivant Sciences LtdROIV | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Buy | $77.00 | N/A | Maintains | 2 years ago |
Neumora Therapeutics IncNMRA | 1 | Strong Buy | $22.00 | N/A | Initiates Coverage On | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 2 years ago |
Eyepoint Pharmaceuticals IncEYPT | 2 | Strong Buy | $55.00 | N/A | Maintains | 2 years ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $736.00 | N/A | Maintains | 2 years ago |
Biogen IncBIIB | 3 | Strong Buy | $350.00 | N/A | Upgrades | 2 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 2 years ago |
Rapt Therapeutics IncRAPT | 2 | Strong Buy | $384.00 | N/A | Maintains | 2 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 3 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Climb Bio IncCLYM | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 4 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 7 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.